期刊文献+

继发性纤维蛋白原缺乏症7例报道及文献复习 被引量:2

原文传递
导出
出处 《中国优生与遗传杂志》 2010年第12期134-134,86,共2页 Chinese Journal of Birth Health & Heredity
  • 相关文献

参考文献15

  • 1吴淑燕,王兆钺.纤维蛋白原分子异常的临床意义[J].国外医学(输血及血液学分册),2004,27(6):517-520. 被引量:5
  • 2RichardE,RobertM,主编.尼氏儿科学精要[M].西安:世界图书出版社,1998.204.
  • 3Astigarraga AI, Navajas GA, Fernandez TAA, et al. Difficulties in the diagnosis of familial hemophagocytic lymphohistiocytosis [ J ]. An Esp Pediatr,2002 Feb,56(2) : 168 -70.
  • 4Fietta P, Manganeui P. The hemospha gocytic syndrome ( macrophage activation syndrome ) [ J ]. Minerva Med,2003 Feb, 94 ( 1 ) : 19 - 27.
  • 5Ruha AM, Curry SC, Beuhler M, et al. Initial Postmarbeting experience with crotalidae poly valent immune Fab for treatment of rattlesnake envenomatiom [ J ]. Ann Emerg Med, 2002 Jun, 39 (6) : 609 - 15.
  • 6Yeh JH, Chiu HC. Coagulation abnormalitiecs in serial double - filtration plasmapheresis [ J ]. J Clin Apheresis ,2001,16 ( 3 ) : 139 - 42.
  • 7Subbatina TF, Orlovskii PI, Petrishcher NN. Turbidimetric express method in the assessment of the hemostasis parameters in patients with prosthetic bileallet heart valves [ J ]. Vestn Khir Im I I Grek, 2001, 160(5) :25 -8.
  • 8Vtoh J, Kunitomo R, Hara M. Consumption coagulopahly associated with aneurysms of the abdominal aorta and the bilateal femoral arteries :Report of a case[J]. J Cardiovasc surg Torino,2001 Apr,42(2) : 245 - 8.
  • 9Udayashanker B. Changes in fibrinolytic activity of blood after prostatectomy [ J ]. Indian J Physiol Phannacol, 2000 Oct,44 ( 4 ) : 485 - 90.
  • 10Salzer Muhar U, Pabinger Fasehing I, Zaeherl Wightman S. Is there apossible role for haemostasis in the development of pefigraft reaction comp licating the modified Blalock Taussig sham? [ J ]. Cardiol Young,2000 May,10(3) :261 4.

二级参考文献17

  • 1van't Hooft FM, yon Bahr SJ, Silveira A, et al. Two common,functional polymorphisms in the promoter region of the betafibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol, 1999, 19 (12):3063-3070.
  • 2Attanasio C, David A, Neerman-Arbez M. Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA). Blood, 2003,101(5):1851-1856.
  • 3Asselta R, Spena S, Duga S, et al. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.Haematologica, 2002,87 (8) : 855-859.
  • 4Stucki B, Zenhausern R, Biedermann B, et al. Fibrinogens Bern Ⅳ, Bern Ⅴ and Milano Ⅺ: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the A alpha-chain. Blood Coagulation & Fibrinolysis, 1999,10 (2): 93-9
  • 5Vlietman J J, Verhage J, Vos HL, et al. Congenital afibrinogenemia in a newborn infant due to a novel mutation in the fibrinogen aalpha gene. Br J Haematol, 2002,119 (1): 282-283.
  • 6Neerman-Arbez M, Honsberger A, Antonarakis SE, et al.Deletion of the fibrinogen alpha-chain gene (FGA) causes congenital afibrinogenemia. J Clin Invest, 1999,103: 215-218.
  • 7Neerman-Arbez M. The molecular basis of inherited afibrinogenemia. Thromb Haemost, 2001,89(1) :154-163.
  • 8Spena S, Duga S, Asselta R, et al. Congenital afibrinogenemia:first identification of splicing in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites. Blood, 2002,100 (13):4478-4484.
  • 9Remijn JA, Van Wijk R, Nieuwenhuis HK, et al. Molecular of congenital afibrinogenemia in a Dutch family. Blood Coagulation & Fibrinolysis, 2003,14 (3): 299-302.
  • 10Vu D, Bolton-Maggs PH, Parr JR, et al. Congenital afibrinogenemia: identification and expressing of a missense mutation in FGB impairing fibrinogen secretion. Blood, 2003,102(13): 4413-4415.

共引文献4

同被引文献24

  • 1李熙鸿.先天性纤维蛋白原缺乏症一例[J].中华医学遗传学杂志,2006,23(1):113-113. 被引量:1
  • 2Sorensen B,Larsen OH,Rea CJ,et al. Fibrinogen as a hemostatic agent[J]. Semin Thromb Hemost, 2012,38 (3) : 268-273.
  • 3Kohler S, Schmid F, Settanni G. The internal dynamics of fibrino- gen and its implications for coagulation and adsorption[J]. PLoS Comput Biol,2015,11 (9) : e1004346.
  • 4Moerloose P,Casini A,Neerman-Arbez M. Congenital fibrinogen disorders : an update[J]. Semin Thromb Hemost, 2013,39 (6) : 585-595.
  • 5Peyvandi F. Epidemiology and treatment of congenital fibrinogen defieiency[J]. Thromb Res,2012,130(Suppl 2) : 7-11.
  • 6Maung AA,Kaplan LJ. Role of fibrinogen in massive injury[J]. Min- erva Anestesiol, 2014,80( 1 ) : 89-95.
  • 7Yin Z,Xu J,Li Y,et ah Transient hypofibrinogenemia due to allop- urinol[J]. Drug Des Devel Ther,2014,8: 1231-1233.
  • 8Moroga Y,Takata H,Yoshida N,et al. Hypofibrinogenemia associ- ated with steroid therapy for the patients who developed GVHD after allogeneic stem cell transplantation][J]. Rinsho Ketsueki,2015,56(7): 883-888.
  • 9Gallastegui N, Kimble EL, Harrington TJ. Resolution of fibrinogen deficiency in a patient with congenital afibrinogenemia after liver trans- plantation[J]. Haemophilia, 2015.1-4.
  • 10Sail S,Yilmaz G,Gonul II,et al. Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child[J]. Liver Int, 2015,35 (12):2501-2505.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部